Disruption of the topologically associated domain at Xp21.2 is related to 46,XY gonadal dysgenesis.

gene expression regulation gene rearrangement high-throughput nucleotide sequencing sequence analysis, DNA sex determination processes

Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
05 2023
Historique:
received: 29 04 2022
accepted: 25 08 2022
medline: 24 4 2023
pubmed: 14 10 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

Duplications at the Xp21.2 locus have previously been linked to 46,XY gonadal dysgenesis (GD), which is thought to result from gene dosage effects of Patients with 46,XY GD were analysed by whole genome sequencing. Identified structural variants were confirmed by array CGH and analysed by high-throughput chromosome conformation capture (Hi-C). We identified two unrelated patients: one showing a complex rearrangement upstream of Here we present a general mechanism how deletions, duplications or inversions at the

Sections du résumé

BACKGROUND
Duplications at the Xp21.2 locus have previously been linked to 46,XY gonadal dysgenesis (GD), which is thought to result from gene dosage effects of
METHODS
Patients with 46,XY GD were analysed by whole genome sequencing. Identified structural variants were confirmed by array CGH and analysed by high-throughput chromosome conformation capture (Hi-C).
RESULTS
We identified two unrelated patients: one showing a complex rearrangement upstream of
CONCLUSION
Here we present a general mechanism how deletions, duplications or inversions at the

Identifiants

pubmed: 36227713
pii: jmg-2022-108635
doi: 10.1136/jmg-2022-108635
pmc: PMC10176412
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

469-476

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Int J Endocrinol. 2012;2012:504904
pubmed: 22518125
Cell. 2015 May 21;161(5):1012-1025
pubmed: 25959774
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Eur J Endocrinol. 2018 Oct 01;179(4):R197-R206
pubmed: 30299888
J Clin Endocrinol Metab. 2007 Aug;92(8):3305-13
pubmed: 17504899
Horm Res Paediatr. 2012;77(2):100-7
pubmed: 22456342
Nat Rev Genet. 2018 Jul;19(7):453-467
pubmed: 29692413
Cell Rep. 2018 Feb 6;22(6):1589-1599
pubmed: 29425512
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Development. 2004 May;131(9):1891-901
pubmed: 15056615
BMC Med Genet. 2016 Mar 15;17:23
pubmed: 26980296
Clin Genet. 2017 Feb;91(2):143-156
pubmed: 27893151
Nat Cell Biol. 2019 Mar;21(3):305-310
pubmed: 30742094
Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):607-19
pubmed: 26303087
Bioinformatics. 2012 Sep 15;28(18):i333-i339
pubmed: 22962449
Nat Genet. 2018 Oct;50(10):1463-1473
pubmed: 30262816
J Clin Endocrinol Metab. 2016 Dec;101(12):4532-4540
pubmed: 27603905
Genet Med. 2018 Jul;20(7):717-727
pubmed: 29261182
Am J Hum Genet. 2020 Jun 4;106(6):872-884
pubmed: 32470376
Nat Genet. 1996 Apr;12(4):404-9
pubmed: 8630494
J Clin Endocrinol Metab. 1999 Feb;84(2):627-31
pubmed: 10022428
Nature. 2016 Oct 13;538(7624):265-269
pubmed: 27706140
Nat Genet. 2017 Jan;49(1):65-74
pubmed: 27869826
Genome Biol. 2016 Nov 29;17(1):243
pubmed: 27899157
Mol Biol Rep. 2019 Jun;46(3):2971-2978
pubmed: 30879272
PLoS One. 2011 Mar 07;6(3):e17793
pubmed: 21408189
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Dec 10;35(6):804-807
pubmed: 30512150
Hum Mutat. 2011 Dec;32(12):1492-9
pubmed: 21948517
Hum Genet. 1996 Jan;97(1):79-86
pubmed: 8557267
Science. 2016 Mar 25;351(6280):1454-1458
pubmed: 26940867
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Genome Biol. 2014 Sep 04;15(9):423
pubmed: 25315429
J Clin Endocrinol Metab. 2010 May;95(5):2399-409
pubmed: 20200336
Nat Genet. 1994 Aug;7(4):497-501
pubmed: 7951319
Hum Reprod. 2010 Oct;25(10):2637-46
pubmed: 20685758
Clin Genet. 2008 May;73(5):453-64
pubmed: 18384427
Hum Genet. 2007 Aug;122(1):63-70
pubmed: 17503084
Nature. 1998 Feb 19;391(6669):761-7
pubmed: 9486644

Auteurs

Jakob A Meinel (JA)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Endocrinology and Diabetes, Universität zu Lübeck, Lubeck, Germany.

Verónica Yumiceba (V)

Institute of Human Genetics, Universität zu Lübeck, Lübeck, Germany.

Axel Künstner (A)

Group of Medical Systems Biology, Lübeck Institute of Experimental Dermatology, Universität zu Lübeck, Lübeck, Germany.
Institute for Cardiogenetics, Universität zu Lübeck, Lübeck, Germany.

Kristin Schultz (K)

Institute of Human Genetics, Universität zu Lübeck, Lübeck, Germany.

Nathalie Kruse (N)

Institute of Human Genetics, Universität zu Lübeck, Lübeck, Germany.

Frank J Kaiser (FJ)

Institute of Human Genetics, Universität Duisburg-Essen, Duisburg, Germany.
Essen Center for Rare Diseases (EZSE), University Hospital Essen, Essen, Germany.

Paul-Martin Holterhus (PM)

University Medical Center for Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine I, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.

Alexander Claviez (A)

Department of Pediatrics and Adolescent Medicine I, Division of Pediatric Oncology and Hematology, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.

Olaf Hiort (O)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Endocrinology and Diabetes, Universität zu Lübeck, Lubeck, Germany.

Hauke Busch (H)

Group of Medical Systems Biology, Lübeck Institute of Experimental Dermatology, Universität zu Lübeck, Lübeck, Germany.
Institute for Cardiogenetics, Universität zu Lübeck, Lübeck, Germany.

Malte Spielmann (M)

Institute of Human Genetics, Universität zu Lübeck, Lübeck, Germany.
Partner Site Hamburg/Kiel/Lübeck, German Center for Cardiovascular Disease, Berlin, Germany.

Ralf Werner (R)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Endocrinology and Diabetes, Universität zu Lübeck, Lubeck, Germany ralf.werner@uni-luebeck.de.
Institute of Molecular Medicine, Universität zu Lübeck, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH